The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

12 May 2021 08:28

RNS Number : 3554Y
Morgan Stanley & Co. Int'l plc
12 May 2021
 

 

12 May 2021

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Permanent TSB Group Holdings p.l.c

Pre-stabilisation Period Announcement

Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Matteo Benedetto; telephone: +44 20 7677-3409) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 and the UK FCA Stabilisation Binding Technical Standards.

Securities

Issuer:

Permanent TSB Group Holdings p.l.c

Guarantor (if any):

N/A

Aggregate nominal amount:

TBC

Description:

Fixed Rate Reset Callable Tier 2 Capital Notes

 

Offer price:

TBC

Stabilisation

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

Banco Santander, S.A.

Goldman Sachs International

NatWest Markets Plc

Stabilisation period expected to start on:

12 May 2021

Stabilisation period expected to end no later than:

11 June 2021 (30 days after the proposed issue date of the securities)

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable laws and rules.

Stabilisation trading venue:

Irish Stock Exchange (Euronext Dublin), Regulated Market

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAATMRTMTTBMIB
Date   Source Headline
8th Nov 20187:00 amRNSTrading Statement
5th Nov 20184:30 pmRNSDirectorate Change
31st Oct 20187:00 amRNSDirector Declaration
4th Oct 201810:38 amRNSDirector Declaration
3rd Oct 201811:00 amRNSDirectorate Change
30th Aug 20188:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNS2018 Half-Year Results Commentary
31st Jul 20182:15 pmRNSSale of Non Performing Loan Portfolio
27th Jul 20187:00 amRNSDirectorate Change
24th Jul 201811:13 amRNSDirectorate Change
24th Jul 201811:00 amRNSDirectorate Change
16th May 20185:43 pmRNSResult of AGM
16th May 20185:15 pmRNSDirectorate Change
16th May 20187:00 amRNSTrading Statement
13th Apr 20182:00 pmRNSNotice of AGM
6th Apr 20183:00 pmRNSCourt approval for cancellation of deferred shares
29th Mar 201811:34 amRNSAnnual Financial Report
14th Mar 20187:00 amRNS2017 Annual Results Commentary
14th Mar 20187:00 amRNSAnnual Financial Report
21st Dec 20177:00 amRNS2017 Supervisory Review and Evaluation Process
13th Dec 20175:40 pmRNSDirector Declaration
29th Nov 201712:00 pmRNSDirectorate Change
8th Nov 20177:00 amRNSTrading Statement
18th Aug 20173:00 pmRNSHolding(s) in Company
16th Aug 20173:00 pmRNSHolding(s) in Company
15th Aug 201711:00 amRNSHolding(s) in Company
8th Aug 20172:00 pmRNSHolding(s) in Company
27th Jul 201710:00 amRNSHalf-year Report
26th Jul 20177:00 amRNS2017 Half-Year Results Commentary
26th Jul 20177:00 amRNSHalf-year Report
8th Jun 20171:00 pmRNSHolding(s) in Company
6th Jun 20172:00 pmRNSHolding(s) in Company
1st Jun 20173:30 pmRNSHolding(s) in Company
1st Jun 20173:30 pmRNSHolding(s) in Company
10th May 20174:45 pmRNSConfirmation of Director Appointment
10th May 20174:45 pmRNSResult of AGM
10th May 20177:00 amRNSTrading Update
12th Apr 201710:00 amRNSNotice of AGM
3rd Apr 201710:00 amRNSAnnual Financial Report
31st Mar 201711:00 amRNSChairman Appointment Update/New Company Secretary
8th Mar 20177:00 amRNSAnnual Financial Report Commentary
8th Mar 20177:00 amRNSAnnual Financial Report
7th Mar 20172:00 pmRNSAppointment of Chairman
16th Feb 20172:00 pmRNSAppointment of Chief Financial Officer
10th Feb 201712:00 pmRNSHolding(s) in Company
21st Dec 20163:00 pmRNSSupervisory Review & Evaluation Process Update
13th Dec 20162:30 pmRNS2016 Supervisory Review and Evaluation Process
18th Nov 201610:00 amRNSCompletion of Asset Sale
10th Nov 20167:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.